About ICT

ICT has developed a unique and highly promising vaccine for cancer therapy.

The Company's initial focus is for patients with lung or breast cancer.

Treatment consists of immunization in patients who have completed conventional treatment. Read more...

Vaccine Strategies

ICT 1001: Lung cancer vaccine in Phase 1 trial, initial positive results. Read more...

ICT 1002: Breast cancer vaccine - Grb10 antigen, IND ready to be filed. Read more...